Celecoxib Impurity 19 | CAS 457639-26-8 - Request Quote
Celecoxib Impurity 19
| SZ CAT No: | SZ-C005029 |
| CAS No | 457639-26-8 |
| Mol.F. | C18H16F3N3O2S |
| Mol.Wt. | 395.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Celecoxib Impurity 19 is chemically 4-(5-(2,5-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide. Celecoxib Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Celecoxib Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Celecoxib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 457639-26-8
Purchase 457639-26-8
Order 457639-26-8
Enquire 457639-26-8
price of 457639-26-8
457639-26-8 Supplier
457639-26-8 Manufacturer
457639-26-8 Exporter
buy high quality Celecoxib Impurity 19
Purchase Celecoxib Impurity 19
Celecoxib Impurity 19 suppliers
Celecoxib Impurity 19 manufacturers
Celecoxib Impurity 19 price
Order Celecoxib Impurity 19
Enquire Celecoxib Impurity 19
Celecoxib Impurity 19 cost
Celecoxib Impurity 19 Supplier
Celecoxib Impurity 19 Distributor
Celecoxib Impurity 19 for Method Validation
Celecoxib Reference Standard
Celecoxib Impurity 19 for ANDA Filing
Celecoxib Impurity 19 for Forced Degradation Studies
Celecoxib Impurity 19 Identification Standards
Celecoxib Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.